Baxter signs over kidney care arm to investment firm in $3.5bn deal – Pharmaceutical Technology
The agreement comes following a March 2024 announcement in which the company detailed that it was looking to either spin out or sell off its
The agreement comes following a March 2024 announcement in which the company detailed that it was looking to either spin out or sell off its
Purdue Pharma has drawn heavy criticism in the past and has been the subject of numerous lawsuits as many accuse the company of being responsible
The UK Labour Party’s near-landslide victory on 5 July healthcare workers and life science investors have been awaiting Wes Streeting’s next moves. Credit: Shutterstock /
A poll conducted by US broadcaster CNBC found that 77% of respondents considered healthcare to be one of their top issues. Credit: Shutterstock / Luca
Share this article The project is estimated to grow the state’s economy by $4.7bn over the next 12 years. Credit: Shutterstock / Robert Way Japanese
Share this article Significant regulatory changes across numerous medical fields are coming in 2024. credit: Shutterstock / tete_escape Significant regulatory changes across numerous medical fields
Share this article The approval means the treatment will be available across all 27 EU member states. Credit: Shutterstock / Karolis Kavolelis. Pfizer’s Elrexfio for
Share this article Following the announcement on 19 November, Bayer’s stock value dropped from €41.45 ($45.38) per share down to €30.77 ($33.68), as of 28
Share this article The deal is set to come into effect at the start of 2024 and set to run until 2028. Credit: Shutterstock /
The new appointment comes as part of a cabinet reshuffle that saw Steve Barclay leaving his post. Credit: Shutterstock / Ink Drop The UK Prime